摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-3-氨基-2-氧杂环酮对甲苯磺酸 | 149572-97-4

中文名称
(R)-3-氨基-2-氧杂环酮对甲苯磺酸
中文别名
(3R)-3-氨基-2-氧杂环丁酮对甲苯磺酸盐
英文名称
(R)-2-oxo-3-oxetanylammonium toluene-4-sulfonate
英文别名
(R)-3-aminooxetan-2-one 4-methylbenzenesulfonate;(3R)-3-aminooxetan-2-one;4-methylbenzenesulfonic acid
(R)-3-氨基-2-氧杂环酮对甲苯磺酸化学式
CAS
149572-97-4
化学式
C3H5NO2*C7H8O3S
mdl
——
分子量
259.283
InChiKey
AHPNSUJOZQROEQ-ARGLLVQISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.11
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    115
  • 氢给体数:
    2
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2932209090

反应信息

  • 作为反应物:
    描述:
    (R)-3-氨基-2-氧杂环酮对甲苯磺酸2-萘甲酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 2.5h, 以20%的产率得到(R)-N-(2-oxo-3-oxetanyl)-2-naphthamide
    参考文献:
    名称:
    Synthesis and Structure−Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors
    摘要:
    The fatty acid ethanolamides (FAEs) are a family of bioactive lipid mediators that include the endogenous agonist of peroxisome proliferator-activated receptor-alpha, palmitoylethanolamide (PEA). FAEs are hydrolyzed intracellularly by either fatty acid amide hydrolase or N-acylethanolamine-hydrolyzing acid amidase (NAAA). Selective inhibition of NAAA by (S)-N-(2-oxo-3-oxetanyl)-3-phenylpropionamide [(S)-OOPP, 7a] prevents PEA degradation in mouse leukocytes and attenuates responses to proinflammatory stimuli. Starting from the structure of 7a, a series of beta-lactones was prepared and tested on recombinant rat NAAA to explore structure-activity relationships (SARs) for this class of inhibitors and improve their in vitro potency. Following the hypothesis that these compounds inhibit NAAA by acylation of the catalytic cysteine, we identified several requirements for recognition at the active site and obtained new potent inhibitors. In particular, (S)-N-(2-oxo-3-oxetanyl)biphenyl-4-carboxamide (7h) was more potent than 7a at inhibiting recombinant rat NAAA activity (7a, IC(50) = 420 nM; 7h, IC(50) = 115 nM) in vitro and at reducing carrageenan-induced leukocyte infiltration in vivo.
    DOI:
    10.1021/jm100582w
  • 作为产物:
    描述:
    N-叔丁氧羰基-D-丝氨酸(Β-内酯)对甲苯磺酸三氟乙酸 作用下, 反应 0.25h, 以77%的产率得到(R)-3-氨基-2-氧杂环酮对甲苯磺酸
    参考文献:
    名称:
    手性1-(2'-氨基-2'-羧乙基)-1,4-二氢-6,7-喹喔啉-2,3-二酮的合成:α-氨基-3-羟基-5-甲基-4-异恶唑丙酸酯受体激动剂和拮抗剂。
    摘要:
    最近发现的6,7-二取代喹喔啉-2,3-二酮1可以拮抗对α-氨基-3-羟基-5-羟基-4-甲基-4-异恶唑丙酸酯(AMPA)和海藻酸的特异性结合和功能响应。尽管各种研究已经分析了在6和7位具有各种取代基的喹喔啉-2,3-二酮的活性,但是关于N取代作用的信息很少。从1(R1 = R2 = H)。该化合物抑制特异性的[3H] AMPA结合,但不抑制[3H]海藻酸酯结合。QXAA,AMPA和DNQX的IC50值分别为0.69、0.012和0.74 microM。R-和S-对映异构体通过不对称合成制备。S-异构体(2b)在结合测定中的效力比R-异构体(2d)高160倍,IC50值分别为0.23和38 microM。在功能测定中,两种对映异构体都是激动剂,S-异构体的EC50值为3 microM,而R-异构体的EC50值大于1 mM。在6和7位(2a和2c)处的甲基取代导致拮抗剂化合物,其特征在于S
    DOI:
    10.1021/jm950632+
点击查看最新优质反应信息

文献信息

  • Synthesis of Chiral 1-(2‘-Amino-2‘-carboxyethyl)-1,4-dihydro-6,7-quinoxaline-2,3-diones:  α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate Receptor Agonists and Antagonists
    作者:Guoping Sun、Norman J. Uretsky、Lane J. Wallace、Gamal Shams、David M. Weinstein、Duane D. Miller
    DOI:10.1021/jm950632+
    日期:1996.1.1
    A racemic mixture of 1-(2'-amino-2'-carboxyethyl)-1,4-dihydroquinoxaline-2, 3-dione (QXAA, 2, R1 = R2 = H) has been synthesized from 1 (R1 = R2 = H). This compound inhibited specific [3H]AMPA binding but not [3H]kainate binding. IC50 values for QXAA, AMPA, and DNQX were 0.69, 0.012, and 0.74 microM, respectively. The R- and S-enantiomers were prepared by asymmetric synthesis. The S-isomer (2b) was 160-fold
    最近发现的6,7-二取代喹喔啉-2,3-二酮1可以拮抗对α-氨基-3-羟基-5-羟基-4-甲基-4-异恶唑丙酸酯(AMPA)和海藻酸的特异性结合和功能响应。尽管各种研究已经分析了在6和7位具有各种取代基的喹喔啉-2,3-二酮的活性,但是关于N取代作用的信息很少。从1(R1 = R2 = H)。该化合物抑制特异性的[3H] AMPA结合,但不抑制[3H]海藻酸酯结合。QXAA,AMPA和DNQX的IC50值分别为0.69、0.012和0.74 microM。R-和S-对映异构体通过不对称合成制备。S-异构体(2b)在结合测定中的效力比R-异构体(2d)高160倍,IC50值分别为0.23和38 microM。在功能测定中,两种对映异构体都是激动剂,S-异构体的EC50值为3 microM,而R-异构体的EC50值大于1 mM。在6和7位(2a和2c)处的甲基取代导致拮抗剂化合物,其特征在于S
  • Enterobactin and Enantioenterobactin
    作者:Eric R. Marinez、Eric K. Salmassian、Thomas T. Lau、Carlos G. Gutierrez
    DOI:10.1021/jo9520194
    日期:1996.1.1
  • Synthesis and Structure−Activity Relationships of <i>N</i>-(2-Oxo-3-oxetanyl)amides as <i>N</i>-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors
    作者:Carlos Solorzano、Francesca Antonietti、Andrea Duranti、Andrea Tontini、Silvia Rivara、Alessio Lodola、Federica Vacondio、Giorgio Tarzia、Daniele Piomelli、Marco Mor
    DOI:10.1021/jm100582w
    日期:2010.8.12
    The fatty acid ethanolamides (FAEs) are a family of bioactive lipid mediators that include the endogenous agonist of peroxisome proliferator-activated receptor-alpha, palmitoylethanolamide (PEA). FAEs are hydrolyzed intracellularly by either fatty acid amide hydrolase or N-acylethanolamine-hydrolyzing acid amidase (NAAA). Selective inhibition of NAAA by (S)-N-(2-oxo-3-oxetanyl)-3-phenylpropionamide [(S)-OOPP, 7a] prevents PEA degradation in mouse leukocytes and attenuates responses to proinflammatory stimuli. Starting from the structure of 7a, a series of beta-lactones was prepared and tested on recombinant rat NAAA to explore structure-activity relationships (SARs) for this class of inhibitors and improve their in vitro potency. Following the hypothesis that these compounds inhibit NAAA by acylation of the catalytic cysteine, we identified several requirements for recognition at the active site and obtained new potent inhibitors. In particular, (S)-N-(2-oxo-3-oxetanyl)biphenyl-4-carboxamide (7h) was more potent than 7a at inhibiting recombinant rat NAAA activity (7a, IC(50) = 420 nM; 7h, IC(50) = 115 nM) in vitro and at reducing carrageenan-induced leukocyte infiltration in vivo.
  • <i>N</i>-(2-Oxo-3-oxetanyl)carbamic Acid Esters as <i>N</i>-Acylethanolamine Acid Amidase Inhibitors: Synthesis and Structure–Activity and Structure–Property Relationships
    作者:Andrea Duranti、Andrea Tontini、Francesca Antonietti、Federica Vacondio、Alessandro Fioni、Claudia Silva、Alessio Lodola、Silvia Rivara、Carlos Solorzano、Daniele Piomelli、Giorgio Tarzia、Marco Mor
    DOI:10.1021/jm300349j
    日期:2012.5.24
    known and new β-lactone derivatives, focusing on the new class of N-(2-oxo-3-oxetanyl)carbamates. Replacement of the amide group with a carbamate one led to different stereoselectivity for NAAA inhibition and higher intrinsic stability, because of the reduced level of intramolecular attack at the lactone ring. The introduction of a syn methyl at the β-position of the lactone further improved chemical
    N-(2-氧代-3-氧杂环丁烷基)酰胺的β-内酯环是一类具有抗炎特性的N-酰基乙醇胺酸酰胺酶(NAAA)抑制剂,既可抑制NAAA,又可降低化合物的稳定性。在这里,我们研究了一组已知的和新的β-内酯衍生物的结构-活性和结构-性质之间的关系,重点研究了新型的N-(2-oxo-3-oxetanyl)carbamates。用氨基甲酸酯取代酰胺基团导致对NAAA抑制不同的立体选择性和更高的固有稳定性,因为内酯环上分子内攻击的水平降低了。在内酯的β-位引入顺甲基进一步改善了化学稳定性。一种侧链中的叔丁基取代基降低了与牛血清白蛋白的反应性。(2 S,3 R)-2-甲基-4-氧代-3-氧杂环丁烷基氨基甲酸5-苯基戊酯(27,URB913 / ARN077)具有良好的体外效价(IC 50 = 127 nM)抑制NAAA并显示出改善的稳定性。它在血浆中迅速裂解,从而支持其在局部应用中的使用。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物